Retrospective Study
Copyright ©The Author(s) 2020.
World J Clin Cases. Nov 6, 2020; 8(21): 5172-5179
Published online Nov 6, 2020. doi: 10.12998/wjcc.v8.i21.5172
Table 4 Comparison of survival and progression-free survival between the two groups
Follow-up results
S-1 group (n = 47)
Gemcitabine group (n = 47)
t
P value
Progress-free survival (mo)6.63 (1.02)6.25 (0.94)1.8780.064
Survival (mo)13.63 (1.52)13.02 (1.45)1.9910.050